Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Clinical trial NCT03412799 · COMPLETED

Trial details

NCT number: NCT03412799
Sponsor: Panbela Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Metastatic Pancreatic Cancer Stage IV Stage IV Pancreatic Cancer

Start date: 2018-06-04
Primary completion: 2022-02-28
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.